Dose-response curves concentration-effect

Determining anticipated route and magnitude of exposure is an important component in the overall assessment of safety and must be done on a nanomaterial-by-nanomaterial basis, with secondary exposures taken into consideration when necessary. The estimated exposure levels for a nanomaterial may then be compared with the calculated safe dose derived from the hazard identification evaluation. The procedures and factors considered in the exposure assessment process are not expected to be any different for nanomaterials than for larger particles or chemicals. The degree of hazard associated with exposure to any chemical or substance, regardless of its physicochemical characteristics, depends on several factors, including its toxicity, dose-response curve, concentration, route of exposure, duration and/or frequency of exposure. However, depending on the route of anticipated exposure (dermal, inhalation, oral) and types of associated toxicities (local or systemic), a chemical may not pose any risk of adverse effects if there is no... 

FIGURE 2.18 Inotropic and lusitropic responses of guinea pig left atria to (3-adrenoceptor stimulation. Panels A to C isometric tension waveforms of cardiac contraction (ordinates are mg tension abscissae are msec), (a) Effect of 0.3 nM isoproterenol on the waveform. The wave is shortened due to an increase in the rate of diastolic relaxation, whereas no inotropic response (change in peak tension) is observed at this concentration, (b) A further shortening of waveform duration (lusitropic response) is observed with 3 nM isoproterenol. This is concomitant with positive inotropic response (increase maximal tension), (c) This trend continues with 100 nM isoproterenol, (d) Dose-response curves for ino tropy (filled circles) and lusitropy (open circles) in guinea pig atria for isoproterenol, (e) Dose-response curves for inotropy (filled circles) and lusitropy (open circles) in guinea pig atria for the P-adrenoceptor partial agonist prenalterol. Data redrawn from [6]. 

FIGURE 3.6 Classical model of agonism. Ordinates response as a fraction of the system maximal response. Abscissae logarithms of molar concentrations of agonist, (a) Effect of changing efficacy as defined by Stephenson [24], Stimulus-response coupling defined by hyperbolic function Response = stimulus/(stimulus-F 0.1). (b) Dose-response curves for agonist of e = 1 and various values for Ka. 

FIGURE 5.4 Microphysiometry responses of HEK 293 cells transfected with human calcitonin receptor, (a) Use of microphysiometry to detect receptor expression. Before transfection with human calcitonin receptor cDNA, HEK cells do not respond to human calcitonin. After transfection, calcitonin produces a metabolic response, thereby indicating successful membrane expression of receptors, (b) Cumulative concentration-response curve to human calcitonin shown in real time. Calcitonin added at the arrows in concentrations of 0.01, 0.1, 1.10, and lOOnM. Dose-response curve for the effects seen in panel B. 

FIGURE 5.10 Effects of co-expressed G-protein (G ) on neuropeptide NPY4 receptor responses (NPY-4). (a) Dose-response curves for NPY-4. Ordinates Xenopus laevis melanophore responses (increases light transmission). Ordinates logarithms of molar concentrations of neuropeptide Y peptide agonist PYY. Curves obtained after no co-transfection (labeled 0 jig) and co-transfection with cDNA for Gai6. Numbers next to the curves indicate jig of cDNA of Ga]g used for co-transfection, (b) Maximal response to neuropeptide Y (filled circles) and constitutive activity (open circles) as a function of pg cDNA of co-transfected G g. 

By utilizing complete dose-response curves, the method devised by Barlow, Scott, and Stephenson [9] can be used to measure the affinity of a partial agonist. Using null procedures, the effects of stimulus-response mechanisms are neutralized and receptor-specific effects of agonists are isolated. This method, based on classical or operational receptor theory, depends on the concept of equiactive concentrations of drug. Under these circumstances, receptor stimuli can be equated since it is assumed that equal responses emanate from equal stimuli in any given system. An example of this procedure is given in Section 12.2.1. 

Antagonists can produce varying combinations of dextral displacement and depression of maxima of agonist dose-response curves. The concentration-related effect of an antagonist on the system response to a single concentration of agonist constitutes what will be referred to as an inhibition curve. One of the most straightforward examples... 

FIGURE 11.16 Control dose-response curve and curve obtained in the presence of a low concentration of antagonist. Panel a data points. Panel b data fit to a single dose-response curve. SSqs = 0.0377. Panel c data fit to two parallel dose-response curves of common maximum. SSqc = 0.0172. Calculation of F indicates that a statistically significant improvement in the fit was obtained by using the complex model (two curves F = 4.17, df=7, 9). Therefore, the data indicate that the antagonist had an effect at this concentration. 

Concentration-response curve, a more specific (and technically correct) term for a dose-response curve done in vitro. This curve defines the relationship between the concentrations of a given molecule and the observed pharmacological effect. 

Potency, the concentration (usually molar) of a drug that produces a defined effect. Often, potencies of agonists are defined in terms of EC50 or pECso values. The potency usually does not involve measures of maximal effect but rather only in locations along the concentration axis of dose-response curves. 

Toxic equivalency factors (TEFs) are estimated relative to 2,3,7,8-TCDD, which is assigned a value of 1. They are measures of the toxicity of individual compounds relative to that of 2,3,7,8-TCDD. A variety of toxic indices, measured in vivo or in vitro, have been used to estimate TEFs, including reproductive effects (e.g., embryo toxicity in birds), immunotoxicity, and effects on organ weights. The degree of induction of P450 lAl is another measure from which estimations of TEF values have been made. The usual approach is to compare a dose-response curve for a test compound with that of the reference compound, 2,3,7,8-TCDD, and thereby establish the concentrations (or doses) that are required to elicit a standard response. The ratio of concentration of 2,3,7,8-TCDD to concentration of test chemical when both compounds produce the same degree of response is the TEF. Once determined, a TEF can be used to convert a concentration of a dioxin-like chemical found in an environmental sample to a toxic equivalent (TEQ). 

When a drug is administered to either humans or animals we obviously know the dose but not the concentration at its site of action. In this instance the relationship between the amount of drug and its effect really is a dose-response curve. 

Due to the occurrence of desensitization, the shape of the full relationship between agonist concentration and response cannot be determined from experiments like that illustrated in Figure 6.1 A. In practice, the most accurately determined part of the macroscopic dose-response curve is often at the low concentration limit, where the effects of desensitization on the dose-response curve are small. 

---